Información de la revista
Vol. 27. Núm. 5.
Páginas 367-368 (enero 2001)
Vol. 27. Núm. 5.
Páginas 367-368 (enero 2001)
Acceso a texto completo
Después del levonorgestrel, ¿será la mifepristona (RU486) la siguiente «píldora del día después»?
Visitas
6701
F. López de Castro, N. Campos Campos, S. Castillo Portales, F.J. Rodríguez Alcalá
Centro de Salud Santa María de Benquerencia, Unidad Docente de Medicina de Familia y Comunitaria de Toledo
Este artículo ha recibido
Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
O. Heikinheimo, D.F. Archer.
Mifepristona: un anticonceptivo potencial.
Clin Obstetr Ginecol, 2 (1996), pp. 425-430
[2.]
E.E. Baulieu, A. Ulmann.
Antiprogesterone activity of RU 486 and its contraceptive and other applications.
Hum Reprod, 1 (1986), pp. 107-110
[3.]
E. Baulieu.
Fertility control in women: results with RU 486 by the end of 1985.
J Steroid Biochem, 25 (1986), pp. 847-851
[4.]
A. Ulmann.
The antiprogestins: a recent advance in fertility regulation.
J Steroid Biochem, 27 (1987), pp. 1009-1012
[6.]
O. Heikinheimo, O. Ylikorkala, P. Lahteenmaki.
Antiprogesterone RU 486.
Ann Med, 22 (1990), pp. 75-84
[7.]
P.F. Van Look, H. Von Hertzen.
Clinical uses of antiprogestogens.
Hum Reprod Update, 1 (1995), pp. 19-34
[8.]
A. Glasier, K.J. Thong, M. Dewar, M. Mackie, D.T. Baird.
Mifepristone (RU 486) compared with high-dose estrogen and progestogen for emergency postcoital contraception.
N Engl J Med, 327 (1992), pp. 1041-1044
[9.]
A.M. Webb, J. Russell, M. Elstein.
Comparison of Yuzpe regimen, danazol, and mifepristone (RU 486) in oral poscoital contraception.
BMJ, 305 (1992), pp. 927-931
[10.]
I.M. Spitz, P.F. Van Look, H.J. Coelingh Bennink.
The use of progesterone antagonist and progesterone receptor modulatros in contraception.
Steroids, 65 (2000), pp. 817-823
[12.]
X. Han, L. Weng, B. Xiao.
Emergency contraception with mifepristone and anordrin.
Chung Hua Fu Chang ko Tsa Chih, 31 (1996), pp. 526-529
[13.]
Task Force on Postovulatory Methods of Fertility Regulation.
Comparison of three single doses of mifepristone as emergency contraception: randomised trial.
Lancet, 353 (1999), pp. 697-702
[14.]
S. Wu, C. Wang, W. Cheng, S. Zuo, H. Li, et al.
Levonorgestrel versus low dose mifepristone for emergency contraception.
Interventions for emergency contraception,
[15.]
Y. Zhang, G. Qiao, P. Zhu, S. Zhang, J. Zhang, N. Zhu.
Clinical observation of three lower doses of mifepristone for emergency contraception.
Chinese J Fam Plan, 8 (1998), pp. 343-345
[16.]
L. Cheng, A.M. Gülmezoglu, E. Ezcurra, P.F.A. Van Look.
Interventions for emergency contraception.
Cochrane Library, (2000),
[17.]
R.E. Wertheimer.
Emergency postcoital contraception.
Am Fam Physician, 62 (2000), pp. 2287-2292
[18.]
P.C. Ho.
Emergency contraception: methods and efficacy.
Curr Opin Obstet Gynecol, 12 (2000), pp. 175-179
[19.]
M. Kettel, J. Liu, A. Murphy, A. Ullmann, J. Mortola, S. Yen.
Endocrine responses to long-term administration of the antiprogesterone RU-486 in patients with pelvic endometriosis.
Fertil Steril, 56 (1999), pp. 402-407
[20.]
A.B. Schein.
Pregnancy prevention using emergency contraception: efficacy, attitudes and limitations to use.
J Pedriatr Adolesc Gynecol, 12 (1999), pp. 3-9
Copyright © 2001. Elsevier España, S.L.. Todos los derechos reservados